Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02AFI
|
||||
| Former ID |
DNC014358
|
||||
| Drug Name |
1-D-glucopyranosyl cytosine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C10H15N3O6
|
||||
| Canonical SMILES |
C1=CN(C(=O)N=C1N)C2C(C(C(C(O2)CO)O)O)O
|
||||
| InChI |
1S/C10H15N3O6/c11-5-1-2-13(10(18)12-5)9-8(17)7(16)6(15)4(3-14)19-9/h1-2,4,6-9,14-17H,3H2,(H2,11,12,18)/t4-,6-,7+,8-,9-/m1/s1
|
||||
| InChIKey |
YYUQXKHCNLFJNF-DDIGBBAMSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Glycogen phosphorylase, muscle form | Target Info | Inhibitor | [1] | |
| BioCyc Pathway | Glycogenolysis | ||||
| KEGG Pathway | Starch and sucrose metabolism | ||||
| Metabolic pathways | |||||
| Insulin signaling pathway | |||||
| Glucagon signaling pathway | |||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| WikiPathways | Glycogen Metabolism | ||||
| Metabolism of carbohydrates | |||||
| References | |||||
| REF 1 | Bioorg Med Chem. 2010 May 15;18(10):3413-25. Epub 2010 Apr 7.1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.